CompuGroup Medical Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/20/2025)
| Balance Sheet | Total Assets | 1,965,670,000.00 | ROE | – |
| Balance Sheet | Total Equity | 647,914,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -63,226,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 65,656,000.00 | – | – |
| Cashflow | Operating Cash Flow | 128,882,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.67 | Div. Yield | – |
| Income | Net Income | 34,600,000.00 | P/E | – |
| Income | Shares Outstanding | 51,734,600.00 | P/B | – |
| Income | Total Revenue | 1,153,990,000.00 | P/S | – |
Ratios calculated on: –
Company Description
CompuGroup Medical AG is a Germany-based holding company engaged in the provision of e-health solutions. The Company operates in three market segments: Health Provider Services (HPS), that offers information system for physicians and pharmacists with focus on their medical and administrative tasks; Health Connectivity Services (HCS), that offers provision and exchange of medical knowledge and data, as well as operates as Internet Service Provider (ISP) offering Internet and Intranet services for the healthcare sector, and Consumer Health Services (CHS), which offers electronic patient services for health related information for patients. The Company's product and solutions portfolio is dividend into 10 product groups: physicians, social facilities, industry, dentists, specialist laboratories, patients, hospitals, pharmacies, rehabilitation centers and insurance companies
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.cgm.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more